---

Rachel Loewy, PhD

EPI-CAL Site Principal Investigator,
Associate Professor, Department of Psychiatry,
Weill Institute for Neurosciences,
University of California, San Francisco

Dr. Loewy is a co-investigator on this study focusing on the development of the DUP measure and collaborating on the early psychosis clinic network. She held a co-founding position developing some of the first community-based early psychosis (EP) coordinated specialty care (CSC) clinics in CA, which utilized a shared standardized data collection system over 5 counties, as well as founding the CSC clinic at UCSF. She has experience in clinical services research and expertise in early psychosis symptom assessment and measure development. Dr. Loewy is recognized as a national expert in community-based treatment of early psychosis as reflected by membership on the PhenX Early Psychosis Clinical Services Working Group panel and contributor to several SAMHSA-contracted EP guidance documents.

---